Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 21532271 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | adverse drug reaction | NA | NA | NA | unclassified | |
| reports have indicated a relationship between adverse drug reaction (adr) and human leukocyte antigen (hla) polymorphism and a relationship between body constitution (bc) and hla polymorphism. | |||||||
| 28346841 | HLA-B*57 | abacavir | Tibetan | flucloxacillin | NA | positive | |
| NA | |||||||
| 30093715 | HLA (HLA) | adverse drug reaction | NA | NA | NA | unclassified | |
| cross-ethnicity tagging snps for hla alleles associated with adverse drug reaction. | |||||||
| 30093715 | HLA (HLA) | adverse drug reaction | NA | NA | NA | unclassified | |
| reduction of adverse drug reaction (adr) incidence through screening of predisposing human leucocyte antigen (hla) alleles is a promising approach for many widely used drugs. | |||||||
| 31089385 | HLA (HLA) | adverse drug reaction | Iranian | carbamazepine | NA | unclassified | |
| epidemiology of severe cutaneous adverse drug reaction and its hla association among pediatrics. | |||||||
| 34034396 | HLA (HLA) | adverse drug reaction | NA | NA | NA | unclassified | |
| hla genotyping before administration can significantly reduce the incidence of severe cutaneous adverse drug reaction related to certain drugs. | |||||||
| 34034396 | HLA (HLA) | adverse drug reaction | NA | NA | NA | unclassified | |
| since limited hla alleles are found, hla genotyping can only prevent adverse drug reaction to a limited extent. | |||||||
| 21734950 | HLA (HLA) | ameloblastoma | NA | NA | NA | only_studied | |
| a possible 'transitional' form of da, showing microscopic features of the desmoplastic variant together with areas typical of classic follicular or plexiform ameloblastoma, has been described as a 'hybrid' lesion of ameloblastoma (hla). | |||||||
| 21738815 | HLA (HLA) | vascular malformations | NA | NA | NA | unclassified | |
| purposethe purpose of our study was to describe the morphological features of gastrointestinal vascular malformations (vm) and of hemangiolymphangiomas (hla) and to establish correlations with clinical characteristics. | |||||||
| 28928923 | HLA (HLA) | vascular malformations | NA | NA | NA | unclassified | |
| hemangiolymphangiomas (hla) are extremely rare vascular malformations of both lymphatic and blood vessels in which 80-90% are diagnosed during the first 2 years of life. | |||||||
Copyright 2024